150 related articles for article (PubMed ID: 7855308)
1. TEI-3356, a highly selective agonist for the prostaglandin EP3 receptor.
Negishi M; Harazono A; Sugimoto Y; Hazato A; Kurozumi S; Ichikawa A
Prostaglandins; 1994 Nov; 48(5):275-83. PubMed ID: 7855308
[TBL] [Abstract][Full Text] [Related]
2. 7,7-Difluoroprostacyclin derivative, AFP-07, a highly selective and potent agonist for the prostacyclin receptor.
Chang CS; Negishi M; Nakano T; Morizawa Y; Matsumura Y; Ichikawa A
Prostaglandins; 1997 Feb; 53(2):83-90. PubMed ID: 9112287
[TBL] [Abstract][Full Text] [Related]
3. Regulation of expression of matrix metalloproteinase-9 in early human T cells of the HSB.2 cultured line by the EP3 subtype of prostaglandin E2 receptor.
Zeng L; An S; Goetzl EJ
J Biol Chem; 1996 Nov; 271(44):27744-50. PubMed ID: 8910368
[TBL] [Abstract][Full Text] [Related]
4. Selective regulation of RNK-16 cell matrix metalloproteinases by the EP4 subtype of prostaglandin E2 receptor.
Zeng L; An S; Goetzl EJ
Biochemistry; 1996 Jun; 35(22):7159-64. PubMed ID: 8679543
[TBL] [Abstract][Full Text] [Related]
5. Functional interaction of the carboxylic acid group of agonists and the arginine residue of the seventh transmembrane domain of prostaglandin E receptor EP3 subtype.
Chang C; Negishi M; Nishigaki N; Ichikawa A
Biochem J; 1997 Mar; 322 ( Pt 2)(Pt 2):597-601. PubMed ID: 9065782
[TBL] [Abstract][Full Text] [Related]
6. Proteinase-activated receptor-2 stimulates prostaglandin production in keratinocytes: analysis of prostaglandin receptors on human melanocytes and effects of PGE2 and PGF2alpha on melanocyte dendricity.
Scott G; Leopardi S; Printup S; Malhi N; Seiberg M; Lapoint R
J Invest Dermatol; 2004 May; 122(5):1214-24. PubMed ID: 15140225
[TBL] [Abstract][Full Text] [Related]
7. Lack of interaction between prostaglandin E2 receptor subtypes in regulating adenylyl cyclase activity in cultured rat dorsal root ganglion cells.
Wise H
Eur J Pharmacol; 2006 Mar; 535(1-3):69-77. PubMed ID: 16545798
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation.
Meja KK; Barnes PJ; Giembycz MA
Br J Pharmacol; 1997 Sep; 122(1):149-57. PubMed ID: 9298541
[TBL] [Abstract][Full Text] [Related]
9. Prostaglandin E receptor subtypes in cultured rat microglia and their role in reducing lipopolysaccharide-induced interleukin-1beta production.
Caggiano AO; Kraig RP
J Neurochem; 1999 Feb; 72(2):565-75. PubMed ID: 9930728
[TBL] [Abstract][Full Text] [Related]
10. Potent contractile actions of prostanoid EP3-receptor agonists on human isolated pulmonary artery.
Qian YM; Jones RL; Chan KM; Stock AI; Ho JK
Br J Pharmacol; 1994 Oct; 113(2):369-74. PubMed ID: 7834185
[TBL] [Abstract][Full Text] [Related]
11. Growth regulation of primary human keratinocytes by prostaglandin E receptor EP2 and EP3 subtypes.
Konger RL; Malaviya R; Pentland AP
Biochim Biophys Acta; 1998 Feb; 1401(2):221-34. PubMed ID: 9531979
[TBL] [Abstract][Full Text] [Related]
12. Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells.
Kiriyama M; Ushikubi F; Kobayashi T; Hirata M; Sugimoto Y; Narumiya S
Br J Pharmacol; 1997 Sep; 122(2):217-24. PubMed ID: 9313928
[TBL] [Abstract][Full Text] [Related]
13. Potentiation of aggregation and inhibition of adenylate cyclase in human platelets by prostaglandin E analogues.
Matthews JS; Jones RL
Br J Pharmacol; 1993 Feb; 108(2):363-9. PubMed ID: 8448586
[TBL] [Abstract][Full Text] [Related]
14. Independent down-regulation of EP2 and EP3 subtypes of the prostaglandin E2 receptors on U937 human monocytic cells.
Zeng L; An S; Goetzl EJ
Immunology; 1995 Dec; 86(4):620-8. PubMed ID: 8567030
[TBL] [Abstract][Full Text] [Related]
15. Characterization of EP-receptor subtypes involved in allodynia and hyperalgesia induced by intrathecal administration of prostaglandin E2 to mice.
Minami T; Nishihara I; Uda R; Ito S; Hyodo M; Hayaishi O
Br J Pharmacol; 1994 Jul; 112(3):735-40. PubMed ID: 7921597
[TBL] [Abstract][Full Text] [Related]
16. Characterization and regulation of prostaglandin E2 receptor and receptor-coupled functions in the choroidal vasculature of the pig during development.
Abran D; Dumont I; Hardy P; Peri K; Li DY; Molotchnikoff S; Varma DR; Chemtob S
Circ Res; 1997 Apr; 80(4):463-72. PubMed ID: 9118476
[TBL] [Abstract][Full Text] [Related]
17. Investigation of the prostaglandin E (EP-) receptor subtype mediating relaxation of the rabbit jugular vein.
Lawrence RA; Jones RL
Br J Pharmacol; 1992 Apr; 105(4):817-24. PubMed ID: 1324050
[TBL] [Abstract][Full Text] [Related]
18. Two Gs-coupled prostaglandin E receptor subtypes, EP2 and EP4, differ in desensitization and sensitivity to the metabolic inactivation of the agonist.
Nishigaki N; Negishi M; Ichikawa A
Mol Pharmacol; 1996 Oct; 50(4):1031-7. PubMed ID: 8863851
[TBL] [Abstract][Full Text] [Related]
19. Cloning and expression of cDNA for a mouse EP1 subtype of prostaglandin E receptor.
Watabe A; Sugimoto Y; Honda A; Irie A; Namba T; Negishi M; Ito S; Narumiya S; Ichikawa A
J Biol Chem; 1993 Sep; 268(27):20175-8. PubMed ID: 7690750
[TBL] [Abstract][Full Text] [Related]
20. Prostaglandin E2 activates EP2 receptors to inhibit human lung mast cell degranulation.
Kay LJ; Yeo WW; Peachell PT
Br J Pharmacol; 2006 Apr; 147(7):707-13. PubMed ID: 16432506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
